Providers don’t need to endorse ibogaine treatment to take this moment seriously. They need to understand it, respect the risk, and prepare for those already seeking it.
The post Ibogaine and SUD Treatment: Signal, Risk, and the Role of Providers appeared first on MedCity News.
